Predictors of AIS Unfavorable Outcomes

NCT06058884 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

592

Enrollment

OTHER

Sponsor class

Conditions

Ischemic Stroke
Alteplase Adverse Reaction

Interventions

DRUG: Alteplase

Sponsor

Kafrelsheikh University